Private Equity

[ad_1] While rising interest rates made 2023 a great year for cash, it’s a different story

[ad_1] Liberty Media’s Formula One Group takes the “pole position” for TD Cowen’s best ideas in

[ad_1] After spending much of 2023 stuck near $30,000, bitcoin broke above $40,000 last weekend and

[ad_1] Buy now pay later stocks are having an undeniable moment, but analysts are divided on

[ad_1] As the holiday season kicks into full swing and year-end approaches, so does a popularly

[ad_1] Investors should focus on defensive stocks ahead of an expected economic slowdown in 2024, according

[ad_1] Canadian mining giant Cameco Corp. is poised to play a pivotal role in U.S. plans

[ad_1] November brought an almost vertical rally with it. However, markets don’t usually go up and

[ad_1] (This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please

[ad_1] Battered-down biotechnology stock Travere Therapeutics could see a strong turnaround, according to Citi. Analyst Carly